164 related articles for article (PubMed ID: 31035965)
1. CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis.
Torres A; Pac-Sosińska M; Wiktor K; Paszkowski T; Maciejewski R; Torres K
BMC Cancer; 2019 Apr; 19(1):401. PubMed ID: 31035965
[TBL] [Abstract][Full Text] [Related]
2. L1CAM, CA9, KLK6, HPN, and ALDH1A1 as Potential Serum Markers in Primary and Metastatic Colorectal Cancer Screening.
Tieng FYF; Abu N; Sukor S; Mohd Azman ZA; Mahamad Nadzir N; Lee LH; Mutalib NSA
Diagnostics (Basel); 2020 Jun; 10(7):. PubMed ID: 32630086
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Prognostic Values of Serum EpCAM, TGM2, and HE4 Levels in Endometrial Cancer.
Lan T; Mu C; Wang Z; Wang Y; Li Y; Mai Y; Li S; Xu H; Gu B; Luo L; Ma P
Front Oncol; 2020; 10():1697. PubMed ID: 33014844
[No Abstract] [Full Text] [Related]
4. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional nanocatalyst-based ultrasensitive detection of human tissue transglutaminase 2.
Huang Y; Li H; Fan Q; Wang L; Wang Y; Li G
Biosens Bioelectron; 2016 Sep; 83():85-90. PubMed ID: 27107144
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic Signature of Endometrial Cancer.
Troisi J; Sarno L; Landolfi A; Scala G; Martinelli P; Venturella R; Di Cello A; Zullo F; Guida M
J Proteome Res; 2018 Feb; 17(2):804-812. PubMed ID: 29235868
[TBL] [Abstract][Full Text] [Related]
7. Soluble VCAM-1/soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis.
Kuessel L; Wenzl R; Proestling K; Balendran S; Pateisky P; Yotova ; Yerlikaya G; Streubel B; Husslein H
Hum Reprod; 2017 Apr; 32(4):770-779. PubMed ID: 28333208
[TBL] [Abstract][Full Text] [Related]
8. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
9. The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma.
Wen KC; Sung PL; Chou YT; Pan CM; Wang PH; Lee OK; Wu CW
Gynecol Oncol; 2018 Feb; 148(2):383-392. PubMed ID: 29208367
[TBL] [Abstract][Full Text] [Related]
10. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma.
Iliaz R; Akyuz U; Tekin D; Serilmez M; Evirgen S; Cavus B; Soydinc H; Duranyildiz D; Karaca C; Demir K; Besisik F; Kaymakoglu S; Akyuz F
Arab J Gastroenterol; 2016 Dec; 17(4):164-167. PubMed ID: 27916547
[TBL] [Abstract][Full Text] [Related]
11. Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers.
Corrado G; Laquintana V; Loria R; Carosi M; de Salvo L; Sperduti I; Zampa A; Cicchillitti L; Piaggio G; Cutillo G; Falcioni R; Vizza E
J Exp Clin Cancer Res; 2018 Jul; 37(1):139. PubMed ID: 29980240
[TBL] [Abstract][Full Text] [Related]
12. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.
Abdel-Azeez HA; Labib HA; Sharaf SM; Refai AN
Asian Pac J Cancer Prev; 2010; 11(1):111-6. PubMed ID: 20593939
[TBL] [Abstract][Full Text] [Related]
13. Villin1, a diagnostic marker for endometrial adenocarcinoma with high grade nuclear atypia.
Nakamura E; Satoh T; Iwakawa M; Nakawatari M; Oki A; Matsumoto K; Okada S; Minaguchi T; Yoshikawa H; Imai T
Cancer Biol Ther; 2011 Aug; 12(3):181-90. PubMed ID: 21623163
[TBL] [Abstract][Full Text] [Related]
14. Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital.
Prueksaritanond N; Cheanpracha P; Yanaranop M
Asian Pac J Cancer Prev; 2016; 17(3):1489-92. PubMed ID: 27039795
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential serum markers for endometrial cancer using protein expression profiling.
Takano M; Kikuchi Y; Asakawa T; Goto T; Kita T; Kudoh K; Kigawa J; Sakuragi N; Sakamoto M; Sugiyama T; Yaegashi N; Tsuda H; Seto H; Shiwa M
J Cancer Res Clin Oncol; 2010 Mar; 136(3):475-81. PubMed ID: 19756734
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD44 concentration in the serum and peritoneal fluid samples of patients with different stages of endometriosis.
Mashayekhi F; Aryaee H; Mirzajani E; Yasin AA; Fathi A
Arch Gynecol Obstet; 2015 Sep; 292(3):641-5. PubMed ID: 25711649
[TBL] [Abstract][Full Text] [Related]
18. The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer.
Huang HH; Wang YC; Chou YC; Yu MH; Chao TK
PLoS One; 2018; 13(10):e0206685. PubMed ID: 30372483
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
Jiang T; Huang L; Zhang S
BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Risk Stratification of Endometrial Carcinoma: L1CAM as a Biomarker.
Pasanen A; Loukovaara M; Tuomi T; Bützow R
Int J Gynecol Cancer; 2017 Sep; 27(7):1318-1324. PubMed ID: 29059097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
